Timeline
Last
$47.74
-1.35 (-2.75%)
24HR-2.8%
1W+3.7%
1M+7.0%
1Y-54.5%
Valuation
- Market Cap
- $69.2B
- Enterprise Value
- $81.8B
- P/E (TTM)
- 19.33x
- Forward P/E
- 13.88x
- Price / Sales
- 3.30x
- EV / EBITDA
- 14.29x
Cash Flow
- Operating Cash Flow
- —
- Free Cash Flow
- —
- FCF Margin
- —
- Cash Conversion
- —
- Cash / Share
- $1
Margins & Growth
- Gross Margin
- 69.3%
- Operating Margin
- 23.9%
- EBITDA Margin
- 27.3%
- Net Margin
- 17.5%
- Revenue Growth
- 7.5%
- Earnings Growth
- 15.1%
Balance Sheet
- Total Cash
- $1.5B
- Total Debt
- $11B
- Net Cash
- -$9.6B
- Debt / Equity
- 0.42x
- Current Ratio
- —
- Quick Ratio
- —
Returns & Ownership
- Return on Assets
- —
- Return on Equity
- —
- Dividend Yield
- —
- Payout Ratio
- 0.0%
- Beta
- 0.57
- Institutional Ownership
- 93.7%
Latest EPS$0.86+0.0% surprise
Beat rate100%4 print streak
Avg surprise+0.0%vs consensus
Next printOct 21, 2026EPS $0.81
Quarterly EPS vs consensus
4 quarters Actual ConsensusLabels: beat $ · YoY %Revisions 0 up / 26 down
Earnings transcripts
Read management commentary and analyst Q&A.
No transcript dates are available yet for this ticker.
Forward estimates
Consensus expectations and estimate momentum.
PeriodEPSRevenueGrowth
0QSep 2026
$0.81$5.3B+7.4%+1QDec 2026
$0.84$5.4B+4.6%0YDec 2026
$3.30$21.4B+8.0%+1YDec 2027
$3.44$22.3B+4.1%Primary research
Recent company filings
Jump directly to earnings releases, quarterly reports, and material updates.
10-QPeriodic Financial Reports2026-08-038-KCorporate Changes & Voting Matters2026-07-298-KCorporate Changes & Voting Matters2026-07-278-KCorporate Changes & Voting Matters2026-05-188-KCorporate Changes & Voting Matters2026-05-0510-QPeriodic Financial Reports2026-05-018-KCorporate Changes & Voting Matters2026-04-228-KCorporate Changes & Voting Matters2026-02-268-KCorporate Changes & Voting Matters2026-02-2310-KPeriodic Financial Reports2026-02-178-KCorporate Changes & Voting Matters2026-02-058-KCorporate Changes & Voting Matters2026-02-04
BSX stock research · Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use s…
| Last price | $47.7 |
|---|---|
| Day change | -1.35 (-2.75%) |
| Market cap | $69.2B |
| P/E (TTM) | 19.33x |
| Sector | Healthcare |
| Industry | Medical Devices |